Date Filed | Type | Description |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2022 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on GRAYBUG VISION, INC.
Txns:
| Granted 20,000 options to buy
@ $0.984, valued at
$19.7k
Granted 20,000 restricted stock units
@ $0 |
|
06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on GRAYBUG VISION, INC.
Txns:
| Granted 12,500 options to buy
@ $4.07, valued at
$50.9k
|
|
03/26/2021 |
3/A
| SHAFFER CHRISTY L (Director) has filed a Form 3/A on GRAYBUG VISION, INC. |
09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2018 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 11,250 options to buy
@ $10.74, valued at
$120.8k
|
|
12/04/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on G1 Therapeutics, Inc. |
08/16/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Bought 1,100 shares
@ $7, valued at
$7.7k
|
|
07/13/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on G1 Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $15.55, valued at
$311k
|
|
07/05/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 2,632 options to buy
@ $9.11, valued at
$24k
|
|
06/23/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Granted 8,618 options to buy
@ $8.81, valued at
$75.9k
|
|
05/24/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on G1 Therapeutics, Inc.
Txns:
| Converted 99,513 shares
@ $0 Converted 172,331 preferred shares
@ $0 Converted 126,212 preferred shares
@ $0 |
|
05/23/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns:
| Bought 1,100 shares
@ $8, valued at
$8.8k
|
|
05/16/2017 |
3
| SHAFFER CHRISTY L (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
03/22/2017 |
4
| SHAFFER CHRISTY L (Director) has filed a Form 4 on Clearside Biomedical, Inc. |
06/01/2016 |
3
| SHAFFER CHRISTY L (Director) has filed a Form 3 on Clearside Biomedical, Inc. |
12/08/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/13/2009 |
4
| SHAFFER CHRISTY L (President & CEO) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC
Txns:
| Granted 29,500 options to buy
@ $5.1, valued at
$150.5k
|
|
08/13/2009 |
4
| SHAFFER CHRISTY L (President & CEO) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC |
05/18/2009 |
4
| SHAFFER CHRISTY L (President & CEO) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC |
03/20/2009 |
4
| SHAFFER CHRISTY L (President & CEO) has filed a Form 4 on INSPIRE PHARMACEUTICALS INC |
01/11/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |